Knowledge Hub

At Sterling, we are proud of our heritage, strong technical capabilities and compliance credentials but it’s our people and the genuine and passionate way they do business that makes us different.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

At Sterling we believe that whilst science can be complex, partnerships should be simple. That is why we have prepared a range of resources to share our team’s research and expertise, and to help you learn more about Sterling and the services we offer.

Filter Content

Knowledge Hub Articles


Quality from the start: Assessing risk to support success in early phase development


An ammonia-based approach to chilling for pharmaceutical manufacturing


High resolution mass spectrometry for impurity profiling


The rise of complex chemistry in small molecule API development


Biocatalysis whitepaper

Technologies & Services